High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial-Reference-Cited by-同舟云学术

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial

Published:2015-08 Issue:8 Volume:26 Page:1760-1765
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ferreri A.J.M.,Sassone M.,Kiesewetter B.,Govi S.,Scarfò L.,Donadoni G.,Raderer M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/8/1760/16699695/mdv214.pdf

Reference27 articles.

1. Marginal-zone lymphoma;Ferreri;Crit Rev Oncol Hematol,2007

2. Marginal zone lymphomas and infectious agents;Ferreri;Semin Cancer Biol,2013

3. Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production;Aoki;Anticancer Res,2005

4. The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages;Kurdowska;J Antimicrob Chemother,2001

5. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein;Wakasugi;Clin Pharmacol Ther,1998

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View;Cancers;2023-07-27

2. Extranodales Marginalzonenlymphom des mukosaassoziierten lymphatischen Gewebes (MALT-Lymphom);Indolente Lymphome;2023

3. First‐line antibiotic treatment in patients with localized extragastric mucosa‐associated lymphoid tissue lymphoma;eJHaem;2022-11-06

4. Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives;Cancers;2022-06-19

5. Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma;Cancers;2022-02-16